product name Mupirocin
Description: Mupirocin is an isoleucyl t-RNA synthetase inhibitor, which is used in the treatment of bacterial skin infections. Mupirocin is an antibiotic of the monoxycarbolic acid class. The effect of Mupirocin is concentration dependent, being bacteriostatic at low concentrations and bactericidal at high concentrations. It is used topically and is effective against Gram-positive bacteria, including MRSA. Mupirocin is a mixture of several pseudomonic acids, with pseudomonic acid A (PA-A) constituting greater than 90% of the mixture.
References: J Antimicrob Chemother. 2015 Oct;70(10):2681-92; Nat Rev Microbiol. 2010 Apr;8(4):281-9.
500.62
Formula
C26H44O9
CAS No.
12650-69-0
Storage
-20℃ for 3 years in powder form
-80℃ for 2 years in solvent
Solubility (In vitro)
DMSO: 100 mg/mL (199.8 mM)
Water: 46 mg/mL warmed (91.9 mM)
Ethanol: 100 mg/mL (199.8 mM)
Solubility (In vivo)
Synonyms
other peoduct :References PubMed ID：:http://www.ncbi.nlm.nih.gov/pubmed/1941190
| In Vitro |
In vitro activity: Kinase Assay: Cell Assay: |
|---|---|
| In Vivo | |
| Animal model | |
| Formulation & Dosage | |
| References |
